Exicure Inc

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Skokie, IL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

New York, New York--(Newsfile Corp. - January 7, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Exicure, Inc. (NASDAQ: XCUR) between March 11, 2021 and November 15, 2021, inclusive (the "Class Period") of the important February 11, 2022 lead plaintiff deadline.SO WHAT: If you purchased Exicure securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees...

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Exicure, Inc. Investors With Losses to Secure Counsel Before Important February 11 Deadline in Securities Class Action - XCUR

Los Angeles, California--(Newsfile Corp. - January 7, 2022) -  The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Exicure, Inc. ("Exicure" or "the Company") (NASDAQ: XCUR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investor Action Notice: The Schall Law Firm Encourages Investors In Exicure, Inc. With Losses Of $100,000 To Contact The Firm

NEW YORK, Jan. 6, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Exicure, Inc. ("Exicure" or the "Company") (NASDAQ: XCUR).  Such investors are advised to contact Robert S.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims

Los Angeles, California--(Newsfile Corp. - January 6, 2022) -  The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Exicure, Inc. ("Exicure" or "the Company") (NASDAQ: XCUR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investor Action Alert: The Schall Law Firm Encourages Investors In Exicure, Inc. With Losses Of $100,000 To Contact The Firm

Los Angeles, California--(Newsfile Corp. - January 5, 2022) -  The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Exicure, Inc. ("Exicure" or "the Company") (NASDAQ: XCUR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Shareholder Action Reminder: The Schall Law Firm Encourages Investors In Exicure, Inc. With Losses Of $100,000 To Contact The Firm

NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Exicure, Inc. (“Exicure” or the “Company”) (NASDAQ: XCUR) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Exicure securities between March 11, 2021 and November 15, 2021, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/xcu

XCUR Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Exicure, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm

NEW YORK, Jan. 1, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Exicure, Inc. (NASDAQ: XCUR) between March 11, 2021 and November 15, 2021, inclusive (the "Class Period") of the important February 11, 2022 lead plaintiff deadline. SO WHAT: If you purchased Exicure securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Exicure, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - XCUR

New York, New York--(Newsfile Corp. - December 30, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Exicure, Inc. (NASDAQ: XCUR) between March 11, 2021 and November 15, 2021, inclusive (the "Class Period") of the important February 11, 2022 lead plaintiff deadline.SO WHAT: If you purchased Exicure securities during the Class Period you may be entitled to compensation without payment of any out of pocket...

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Exicure, Inc. Investors to Secure Counsel Before Important February 11 Deadline in Securities Class Action - XCUR

NEW YORK, Dec. 23, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Exicure, Inc. (NASDAQ: XCUR) between March 11, 2021 and November 15, 2021, inclusive (the "Class Period") of the important February 11, 2022 lead plaintiff deadline. SO WHAT: If you purchased Exicure securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Exicure, Inc. Investors with Losses to Secure Counsel Before Important February 11 Deadline in Securities Class Action - XCUR

SAN DIEGO--(BUSINESS WIRE)---- $XCUR #Friedreichsataxia--Exicure, Inc. (XCUR) Failed to Disclose Improprieties Associated with its Preclinical Program for the Treatment of Friedreich's Ataxia

XCUR Shareholder Alert: Robbins LLP Reminds Investors of Class Action Against Exicure, Inc. (XCUR)

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming February 11, 2022 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Exicure, Inc. (“Exicure” or the “Company”) (NASDAQ: XCUR) securities between March 11, 2021 and November 15, 2021, inclusive (the “Class Period”). Investors suffering losses on their Exicure investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal r

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Exicure, Inc. (XCUR)

NEW YORK--(BUSINESS WIRE)-- #Exicure--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Exicure, Inc. (NASDAQ: XCUR) between March 11, 2021 and November 15, 2021, inclusive (the “Class Period”) of the important February 11, 2022 lead plaintiff deadline. SO WHAT: If you purchased Exicure securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Exicure, Inc. Investors to Secure Counsel Before Important February 11 Deadline in Securities Class Action – XCUR

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 11, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Exicure, Inc. (“Exicure” or the “Company”) (NASDAQ: XCUR) securities between March 11, 2021 and November 15, 2021, inclusive (the “Class Period”). If you suffered a loss on your Exicure investments or would like to inquire about potentially pursuing c

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Exicure, Inc. (XCUR)

SAN DIEGO--(BUSINESS WIRE)---- $XCUR #classaction--Exicure, Inc. (XCUR) Failed to Disclose Improprieties Associated with its Preclinical Program for the Treatment of Friedreich's Ataxia

XCUR SHAREHOLDERS: Robbins LLP Informs Investors of Class Action Against Exicure, Inc. (XCUR)

CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure, Inc. Announces $11.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Exicure, Inc. Announces $11.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Exicure, Inc. (NASDAQ: XCUR) between March 11, 2021 and November 15, 2021, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 11, 2022. SO WHAT: If you purchased Exicure securities during the Class Period you

EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Exicure, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – XCUR

The stock price of Exicure Inc (NASDAQ: XCUR) increased by over 60% pre-market today. This is why it happened.

Exicure Stock (XCUR): Why The Price Surged Today

NEW YORK--(BUSINESS WIRE)-- #Exicure--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Exicure, Inc. (“Exicure” or the “Company”) (NASDAQ: XCUR) in the United States District Court for the Northern District of Illinois on behalf of all persons and entities who purchased or otherwise acquired Exicure securities between March 11, 2021 and November 15, 2021, both dates included, (the “Class Period”). Investors h

EXICURE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Exicure, Inc. and Encourages Investors to Contact the Firm

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Exicure, Inc. (“Exicure” or the “Company”) (NASDAQ: XCUR) securities between March 11, 2021 and November 15, 2021, inclusive (the “Class Period”). Exicure investors have until February 11, 2022 to file a lead plaintiff motion. Investors suffering losses on their Exicure investments are encouraged to contact the Law Offices of Howard G. Smith to

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Exicure, Inc. (XCUR) Investors

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Northern District of Illinois captioned Colwell v. Exicure, Inc., et al., (Case No. 21-cv-6637) on behalf of persons and entities that purchased or otherwise acquired Exicure, Inc. (“Exicure” or the “Company”) (NASDAQ: XCUR) securities between March 11, 2021 and November 15, 2021, inclusive (the “Class Period”). Plaintiff pursues c

XCUR CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Exicure, Inc.

Exicure Inc's (NASDAQ: XCUR) Audit Committee concluded that Grant Corbett misreported raw data from certain R&D experiments related to XCUR-FXN preclinical program. Dr. Corbett misreported the results of at least three different experiments related solely to efficacy rather than safety.

Exicure Stock Plunges After Results Of Internal Probe, Management Shakeup, Layoffs

CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure, Inc.® (NASDAQ: XCUR) announced the results of its previously disclosed independent internal investigation and a number of strategic actions aimed to reduce cash spend and prioritize the Company's therapeutic pipeline. The Audit Committee of the Board of Directors of the Company (the “Audit Committee”) today announced the findings of the internal investigation initiated and overseen by the Audit Committee and conducted by outside counsel in c

Exicure, Inc. Announces Results of Internal Investigation and Implementation of Strategic Measures to Reduce Cash Burn and Prioritize Pipeline Focus

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Exicure To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - December 7, 2021) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Exicure, Inc. ("Exicure" or the "Company") (NASDAQ: XCUR).If you suffered losses exceeding $100,000 investing in Exicure stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/XCUR.

Exicure Investor Alert

NEW YORK, Dec. 7, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Exicure, Inc. (NASDAQ: XCUR) resulting from allegations that Exicure may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Exicure securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Exicure, Inc. Investors with Losses to Inquire About Class Action Investigation - XCUR

Los Angeles, California--(Newsfile Corp. - December 3, 2021) -  The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Exicure, Inc. ("Exicure" or "the Company") (NASDAQ: XCUR) for violations of the securities laws.The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Exicure filed a Form 12b-25 with the SEC on November 15, 2021,...

INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Exicure, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

News for Exicure Inc Stock (XCUR)